{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:19:34Z","timestamp":1791119974403,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T00:00:00Z","timestamp":1386892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0081835","type":"journal-article","created":{"date-parts":[[2013,12,13]],"date-time":"2013-12-13T21:16:59Z","timestamp":1386969419000},"page":"e81835","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Renal Function Can Improve at Any Stage of Chronic Kidney Disease"],"prefix":"10.1371","volume":"8","author":[{"given":"Lise","family":"Weis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Haymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Thervet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Flamant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vrtovsnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Gauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Froissart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Letavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Stengel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the NephroTest Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1681\/ASN.2009121210","article-title":"Rate of kidney function decline associates with mortality","volume":"21","author":"Z Al-Aly","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJM199403313301301","article-title":"The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group","volume":"330","author":"S Klahr","year":"1994","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","article-title":"Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study","volume":"51","author":"LG Hunsicker","year":"1997","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.ki.5000058","article-title":"The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age","volume":"69","author":"BO Eriksen","year":"2006","journal-title":"Kidney Int"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/sj.ki.5000270","article-title":"Progression of kidney dysfunction in the community-dwelling elderly","volume":"69","author":"BR Hemmelgarn","year":"2006","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"BM Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"African American Study of Kidney Disease and Hypertension Study Group. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"JT Wright Jr","year":"2002","journal-title":"JAMA"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"AS Levey","year":"2011","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1001\/jama.285.21.2719","article-title":"African American Study of Kidney Disease and Hypertension (AASK) Study Group. Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial","volume":"285","author":"LY Agodoa","year":"2001","journal-title":"JAMA"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"EJ Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1681\/ASN.2007090970","article-title":"Role of remission clinics in the longitudinal treatment of CKD","volume":"19","author":"P Ruggenenti","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"PE Pergola","year":"2011","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1681\/ASN.2010111158","article-title":"Nilotinib attenuates renal injury and prolongs survival in chronic kidney disease","volume":"22","author":"M Iyoda","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2010080869","article-title":"Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy","volume":"22","author":"DE Kohan","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1681\/ASN.2010101049","article-title":"Pirfenidone for diabetic nephropathy","volume":"22","author":"K Sharma","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1172\/JCI39569","article-title":"Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome","volume":"120","author":"M Tanaka","year":"2010","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1681\/ASN.V105997","article-title":"In chronic nephropathies prolonged ACE inhibition can induce remission: dynamics of time-dependent changes in GFR. Investigators of the GISEN Group. Gruppo Italiano Studi Epidemiologici in Nefrologia","volume":"10","author":"P Ruggenenti","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1681\/ASN.2011050456","article-title":"for the African-American Study of Kidney Disease and Hypertension Group. Kidney Function Can Improve in Patients with Hypertensive CKD","volume":"23","author":"B Hu","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"ref20","first-page":"16158","article-title":"Thirty years with HIV infection-nonprogression is still puzzling: lessons to be learned from controllers and long-term nonprogressors","volume":"2012","author":"JC Gaardbo","year":"2012","journal-title":"AIDS Res Treat"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1681\/ASN.2008020159","article-title":"Timing of onset of CKD-related metabolic complications","volume":"20","author":"O Moranne","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","article-title":"Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function","volume":"16","author":"M Froissart","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Fleiss JL (2003) Statistical Methods for Rates and Proportions, Third Edition. New York: John Wiley & Sons, Inc.","DOI":"10.1002\/0471445428"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1053\/j.ajkd.2011.12.009","article-title":"Longitudinal progression trajectory of GFR among patients with CKD","volume":"59","author":"L Li","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s11255-008-9360-9","article-title":"Improvement in eGFR in patients with chronic kidney disease attending a nephrology clinic","volume":"40","author":"H Taskapan","year":"2008","journal-title":"Int Urol Nephrol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/ndt\/gfl198","article-title":"Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease","volume":"21","author":"C Jones","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(00)70195-8","article-title":"Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease","volume":"35","author":"T Ecder","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"MC Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1053\/ajkd.2000.8971","article-title":"Diabetes, hemoglobin A(1c), cholesterol, and the risk of moderate chronic renal insufficiency in an ambulatory population","volume":"36","author":"CY Hsu","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/ndt\/gfp475","article-title":"Similar renal decline in diabetic and non-diabetic patients with comparable levels of albuminuria","volume":"25","author":"V Lorenzo","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1681\/ASN.V12122832","article-title":"ACE inhibitors to prevent end-stage renal disease: when to start and why possibly never to stop: a post hoc analysis of the REIN trial results. Ramipril Efficacy in Nephropathy","volume":"12","author":"P Ruggenenti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/01.ASN.0000060574.38107.3B","article-title":"Regression of renal vascular and glomerular fibrosis: role of angiotensin II receptor antagonism and matrix metalloproteinases","volume":"14","author":"JJ Boffa","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1097\/01.ASN.0000095248.91994.D3","article-title":"Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats","volume":"14","author":"M Adamczak","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/ki.1991.200","article-title":"Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions","volume":"40","author":"M Ikoma","year":"1991","journal-title":"Kidney Int"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2215\/CJN.02101205","article-title":"Association of disorders in mineral metabolism with progression of chronic kidney disease","volume":"1","author":"S Schwarz","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"N Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1681\/ASN.2011020175","article-title":"Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE Inhibition","volume":"22","author":"C Zoccali","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","article-title":"Bicarbonate supplementation slows progression of CKD and improves nutritional status","volume":"20","author":"I de Brito-Ashurst","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/j.ajkd.2011.04.029","article-title":"Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD","volume":"58","author":"P Ure\u00f1a-Torres","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2215\/CJN.02640311","article-title":"Serum 25-hydroxyvitamin D and change in estimated glomerular filtration rate","volume":"6","author":"IH de Boer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ki.2008.501","article-title":"Vitamin D levels and patient outcome in chronic kidney disease","volume":"75","author":"P Ravani","year":"2009","journal-title":"Kidney Int"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1681\/ASN.2009030283","article-title":"25-hydroxyvitamin D levels, race, and the progression of kidney disease","volume":"20","author":"ML Melamed","year":"2009","journal-title":"J Am Soc Nephrol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0081835","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,19]],"date-time":"2022-03-19T19:00:16Z","timestamp":1647716416000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0081835"}},"subtitle":[],"editor":[{"given":"Giuseppe","family":"Remuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,13]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0081835","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,13]]}}}